TipRanks
Advertisement
Advertisement

HK:1228 Stock Latest News

CANbridge boosts rare disease footprint after HK$200 million WuXi stake
Company AnnouncementsCANbridge boosts rare disease footprint after HK$200 million WuXi stake
1M ago
1228
CANbridge Wins Taiwan NHIA Reimbursement for Rare Disease Drug Livmarli
PremiumCompany Announcements
CANbridge Wins Taiwan NHIA Reimbursement for Rare Disease Drug Livmarli
2M ago
1228
CANbridge sets August board meeting to approve 2026 interim results
PremiumCompany Announcements
CANbridge sets August board meeting to approve 2026 interim results
2M ago
1228
CANbridge Pharmaceuticals Refreshes Board and Committee Leadership With New Independent Director
PremiumCompany Announcements
CANbridge Pharmaceuticals Refreshes Board and Committee Leadership With New Independent Director
2M ago
1228
CANbridge Pharmaceuticals Details Board and Committee Structure
PremiumCompany Announcements
CANbridge Pharmaceuticals Details Board and Committee Structure
2M ago
1228
CANbridge Shareholders Unanimously Approve WuXi Biologics Service Agreement
PremiumCompany AnnouncementsCANbridge Shareholders Unanimously Approve WuXi Biologics Service Agreement
2M ago
1228
CANbridge Advances North African Expansion for Gaucher Drug Gaurunning
Premium
Company Announcements
CANbridge Advances North African Expansion for Gaucher Drug Gaurunning
2M ago
1228
CANbridge Calls Virtual EGM to Approve WuXi Biologics Service Framework
Premium
Company Announcements
CANbridge Calls Virtual EGM to Approve WuXi Biologics Service Framework
3M ago
1228
CANbridge delays shareholder circular on WuXi Biologics framework deal
PremiumCompany Announcements
CANbridge delays shareholder circular on WuXi Biologics framework deal
3M ago
1228
CANbridge Shareholders Approve All Resolutions at 2026 AGM
PremiumCompany Announcements
CANbridge Shareholders Approve All Resolutions at 2026 AGM
3M ago
1228
CANbridge Sets New Connected Service Deals With WuXi Biologics and Baheal Medical
PremiumCompany Announcements
CANbridge Sets New Connected Service Deals With WuXi Biologics and Baheal Medical
4M ago
1228
CANbridge Sets 2026 Virtual AGM, Seeks Share Issuance Mandate Renewal
PremiumCompany Announcements
CANbridge Sets 2026 Virtual AGM, Seeks Share Issuance Mandate Renewal
4M ago
1228
CANbridge Ties CEO Equity Award to Licensing Milestones and Sales Growth
PremiumCompany AnnouncementsCANbridge Ties CEO Equity Award to Licensing Milestones and Sales Growth
6M ago
1228
CANbridge Reshuffles Key Company Secretary and Compliance Roles After Resignation
Premium
Company Announcements
CANbridge Reshuffles Key Company Secretary and Compliance Roles After Resignation
6M ago
1228
CANbridge deepens Baheal alliance as rare-disease drugs gain regulatory and insurance momentum in China
Premium
Company Announcements
CANbridge deepens Baheal alliance as rare-disease drugs gain regulatory and insurance momentum in China
6M ago
1228
CANbridge Pharmaceuticals Schedules Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
CANbridge Pharmaceuticals Schedules Board Meeting to Approve 2025 Annual Results
7M ago
1228
CANbridge Flags WuXi License Deals as Connected Transactions After New Major Shareholder Entry
PremiumCompany Announcements
CANbridge Flags WuXi License Deals as Connected Transactions After New Major Shareholder Entry
7M ago
1228
CANbridge Completes HK$2.38 New Share Subscription, Reshaping Shareholder Base
PremiumCompany Announcements
CANbridge Completes HK$2.38 New Share Subscription, Reshaping Shareholder Base
7M ago
1228
CANbridge Clarifies Equity Grants to Key R&D and Regulatory Advisers
PremiumCompany Announcements
CANbridge Clarifies Equity Grants to Key R&D and Regulatory Advisers
8M ago
1228
CANbridge to Raise HK$199 Million via Discounted Share Subscription Backed by WuXi Biologics Unit
PremiumCompany AnnouncementsCANbridge to Raise HK$199 Million via Discounted Share Subscription Backed by WuXi Biologics Unit
8M ago
1228
CANbridge Grants Share Options and RSUs Equal to 1.25% of Share Capital
Premium
Company Announcements
CANbridge Grants Share Options and RSUs Equal to 1.25% of Share Capital
9M ago
1228
CANbridge’s CAN 103 Gains Inclusion in China’s Innovative Drug List
Premium
Company Announcements
CANbridge’s CAN 103 Gains Inclusion in China’s Innovative Drug List
10M ago
1228

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >